Performance of the Baxter disposable patient-controlled analgesia infusor under hyperbaric conditions.
Hyperbaric oxygen treatment may require the concurrent administration of drugs. A study was performed to assess the suitability of the infusor device from the Baxter Patient-Controlled Analgesia system, for drug delivery during hyperbaric therapy. Thirty infusor devices were used to deliver 5% dextrose, 50% dextrose or propofol solutions under conditions 1 and 2.3 atmospheres of pressure. The increased pressure caused an increase in flow of 4.27%, 1.79% and 9.84% for 5% dextrose, propofol and 50% dextrose respectively.